CN Patent

CN104004056B — 一种关于Cyclin D蛋白抑制剂多肽及其应用

Assigned to Changzhi Wut Engineering Technology Research Institute · Expires 2016-08-17 · 10y expired

What this patent protects

本发明涉及药物领域，具体涉及具有抑制Cyclin D蛋白表达，治疗套细胞淋巴瘤的多肽。其序列为NLAAMTPAGD是全新的序列，该多肽可体外抑制套细胞淋巴瘤细胞G519细胞增殖、迁移，治疗套细胞淋巴瘤；在体荷瘤模型实验中成功的增加了小鼠的生存率，具有潜在的新药开发价值。

USPTO Abstract

本发明涉及药物领域，具体涉及具有抑制Cyclin D蛋白表达，治疗套细胞淋巴瘤的多肽。其序列为NLAAMTPAGD是全新的序列，该多肽可体外抑制套细胞淋巴瘤细胞G519细胞增殖、迁移，治疗套细胞淋巴瘤；在体荷瘤模型实验中成功的增加了小鼠的生存率，具有潜在的新药开发价值。

Drugs covered by this patent

Patent Metadata

Patent number
CN104004056B
Jurisdiction
CN
Classification
—
Expires
2016-08-17
Drug substance claim
No
Drug product claim
No
Assignee
Changzhi Wut Engineering Technology Research Institute
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.